Pharsight

Drugs that contain Insulin Glargine Recombinant

1. Lantus patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5656722 SANOFI AVENTIS US A21 -, B30 - modified insulin derivatives having an altered action profile
Aug, 2014

(9 years ago)

US5656722

(Pediatric)

SANOFI AVENTIS US A21 -, B30 - modified insulin derivatives having an altered action profile
Feb, 2015

(9 years ago)

US7713930 SANOFI AVENTIS US Acidic insulin preparations having improved stability
Jun, 2023

(10 months ago)

US7476652 SANOFI AVENTIS US Acidic insulin preparations having improved stability
Jul, 2023

(9 months ago)

US7713930

(Pediatric)

SANOFI AVENTIS US Acidic insulin preparations having improved stability
Dec, 2023

(4 months ago)

US7476652

(Pediatric)

SANOFI AVENTIS US Acidic insulin preparations having improved stability
Jan, 2024

(3 months ago)

US7918833 SANOFI AVENTIS US Pen-type injector
Sep, 2027

(3 years from now)

US7918833

(Pediatric)

SANOFI AVENTIS US Pen-type injector
Mar, 2028

(3 years from now)

Market Authorisation Date: 27 April, 2007

Treatment: Treatment of diabetes mellitus

Dosage: INJECTABLE;INJECTION

More Information on Dosage

LANTUS family patents

Family Patents

2. Lantus Solostar patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9408979 SANOFI AVENTIS US Pen-type injector
Mar, 2024

(2 months ago)

US9827379 SANOFI AVENTIS US Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US9610409 SANOFI AVENTIS US Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US9233211 SANOFI AVENTIS US Relating to a pen-type injector
Mar, 2024

(2 months ago)

US9526844 SANOFI AVENTIS US Pen-type injector
Mar, 2024

(2 months ago)

US9604008 SANOFI AVENTIS US Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US8603044 SANOFI AVENTIS US Pen-type injector
Mar, 2024

(2 months ago)

US9775954 SANOFI AVENTIS US Pen-type injector
Mar, 2024

(2 months ago)

US8556864 SANOFI AVENTIS US Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US9011391 SANOFI AVENTIS US Pen-type injector
Mar, 2024

(a month ago)

US8992486 SANOFI AVENTIS US Pen-type injector
Jun, 2024

(a month from now)

US9604009 SANOFI AVENTIS US Drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US9533105 SANOFI AVENTIS US Drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US9623189 SANOFI AVENTIS US Relating to drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US9561331 SANOFI AVENTIS US Drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US8512297 SANOFI AVENTIS US Pen-type injector
Sep, 2024

(4 months from now)

US8679069 SANOFI AVENTIS US Pen-type injector
Apr, 2025

(11 months from now)

US9717852 SANOFI AVENTIS US Cartridge holder and pen-type injector
Apr, 2033

(8 years from now)

Market Authorisation Date: 27 April, 2007

Treatment: Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a rotating drive sleeve; Improvement in glycemic control in diabetes mellitus patients by use of a pen injec...

Dosage: INJECTABLE;INJECTION

More Information on Dosage

LANTUS SOLOSTAR family patents

Family Patents

3. Toujeo Max Solostar patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9526844 SANOFI US SERVICES Pen-type injector
Mar, 2024

(2 months ago)

US9775954 SANOFI US SERVICES Pen-type injector
Mar, 2024

(2 months ago)

US9827379 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US9604008 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US9233211 SANOFI US SERVICES Relating to a pen-type injector
Mar, 2024

(2 months ago)

US9610409 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US9408979 SANOFI US SERVICES Pen-type injector
Mar, 2024

(2 months ago)

US8603044 SANOFI US SERVICES Pen-type injector
Mar, 2024

(2 months ago)

US8556864 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US9011391 SANOFI US SERVICES Pen-type injector
Mar, 2024

(a month ago)

US8992486 SANOFI US SERVICES Pen-type injector
Jun, 2024

(a month from now)

US9604009 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US9533105 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US9623189 SANOFI US SERVICES Relating to drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US9561331 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US8512297 SANOFI US SERVICES Pen-type injector
Sep, 2024

(4 months from now)

US8679069 SANOFI US SERVICES Pen-type injector
Apr, 2025

(11 months from now)

US7918833 SANOFI US SERVICES Pen-type injector
Sep, 2027

(3 years from now)

US9345750 SANOFI US SERVICES Long-acting formulations of insulin
May, 2031

(7 years from now)

US10369291 SANOFI US SERVICES Mechanism for a drug delivery device
Sep, 2035

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Feb 25, 2018
New Patient Population(NPP) Nov 26, 2022

Market Authorisation Date: 25 February, 2015

Treatment: Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a rotating drive sleeve; Improvement in glycemic control in diabetes mellitus patients by use of a pen injec...

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

TOUJEO MAX SOLOSTAR family patents

Family Patents

4. Toujeo Solostar patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9827379 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US9775954 SANOFI US SERVICES Pen-type injector
Mar, 2024

(2 months ago)

US9408979 SANOFI US SERVICES Pen-type injector
Mar, 2024

(2 months ago)

US9233211 SANOFI US SERVICES Relating to a pen-type injector
Mar, 2024

(2 months ago)

US9604008 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US9610409 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US9526844 SANOFI US SERVICES Pen-type injector
Mar, 2024

(2 months ago)

US8603044 SANOFI US SERVICES Pen-type injector
Mar, 2024

(2 months ago)

US8556864 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Mar, 2024

(2 months ago)

US9011391 SANOFI US SERVICES Pen-type injector
Mar, 2024

(a month ago)

US8992486 SANOFI US SERVICES Pen-type injector
Jun, 2024

(a month from now)

US9604009 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US9533105 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US9623189 SANOFI US SERVICES Relating to drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US9561331 SANOFI US SERVICES Drive mechanisms suitable for use in drug delivery devices
Aug, 2024

(3 months from now)

US8512297 SANOFI US SERVICES Pen-type injector
Sep, 2024

(4 months from now)

US8679069 SANOFI US SERVICES Pen-type injector
Apr, 2025

(11 months from now)

US7918833 SANOFI US SERVICES Pen-type injector
Sep, 2027

(3 years from now)

US7918833

(Pediatric)

SANOFI US SERVICES Pen-type injector
Mar, 2028

(3 years from now)

US9345750 SANOFI US SERVICES Long-acting formulations of insulin
May, 2031

(7 years from now)

US10369291 SANOFI US SERVICES Mechanism for a drug delivery device
Sep, 2035

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Feb 25, 2018
New Patient Population(NPP) Nov 26, 2022

Market Authorisation Date: 25 February, 2015

Treatment: Improvement in glycemic control in diabetes mellitus patients by use of a pen injector with a rotating drive sleeve; Improvement in glycemic control in diabetes mellitus patients by use of a pen injec...

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

TOUJEO SOLOSTAR family patents

Family Patents